Jan Marini Ceases Eyelash Product Sales Due To Allergan Suit, FDA Threat
This article was originally published in The Rose Sheet
Executive Summary
Jan Marini Skin Research (JMSR) is suspending sales of its two Age Intervention eyelash products in the U.S. - citing an uncertain regulatory environment and the daunting prospect of litigation - and focusing on its core skin-care line and opportunities abroad